Singapore Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

Want new traffic sources? Download a copy of our complimentary eBook today, and read about sources that most marketers are not aware of. From our sponsors

Singapore Pharmaceuticals and Healthcare Report Q4 2013 Sep 4th 2013, 00:00 Price: $ 1295   BMI View: Despite its small population, foreign pharmaceutical firms will continue to be interested in Singapore given the highly skilled workforce and the success the country had with its biomedical sector, attracting investments into the sector. In addition, the impending launch of the Association of South East Nation Economic Community in 2015 will bring opportunities to Singapore as firms can look to market their products through the whole of ASEAN using Singapore as a base. From the healthcare perspective, the government's promise to improve healthcare provision, alongside with the rising demand for services due to the ageing population will create opportunities for private healthcare players. Headline Expenditure Projections ? Pharmaceuticals: SGD940mn (US$770mn) in 2012 to SGD1.0bn (U ... Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/268984.html

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions